Jazz Pharmaceuticals plc 10-Q for FY2025 Q2
Jazz Pharmaceuticals plc (JAZZ)
10-Q
2025-08-06
For: 2025-06-30
View Original
Added on
April 08, 2026
About this 10-Q
Jazz Pharmaceuticals plc filed this 10-Q on August 6, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.05B
- up 2.1% from $1.02B a year earlier
- Net loss
- $718.47M
- compared with net income of $168.57M a year earlier
- Diluted EPS
- -$11.74
- compared with $2.49 a year earlier